Ets-1 Regulates Energy Metabolism in Cancer Cells
暂无分享,去创建一个
Gurmit Singh | Chris P. Verschoor | C. Verschoor | M. Verschoor | Meghan L. Verschoor | Leigh A. Wilson | L. Wilson | G. Singh
[1] K. Fujikawa,et al. The Ets‐1 and Ets‐2 transcription factors activate the promoters for invasion‐associated urokinase and collagenase genes in response to epidermal growth factor , 1998, International journal of cancer.
[2] Weiya Ma,et al. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced NF-kappaB activation by tea polyphenols, (-)-epigallocatechin gallate and theaflavins. , 2000, Carcinogenesis.
[3] M. Akıncı,et al. Oxidant/antioxidant balance in patients with thyroid cancer. , 2008, Acta cirurgica brasileira.
[4] P. Andrews,et al. Mitochondrial defects in cis-diamminedichloroplatinum(II)-resistant human ovarian carcinoma cells. , 1992, Cancer research.
[5] O. Podhajcer,et al. Imbalance of antioxidant enzymes in tumor cells and inhibition of proliferation and malignant features by scavenging hydrogen peroxide , 2004, Molecular carcinogenesis.
[6] U. Ray,et al. Antioxidant and oxidative stress responses of sojourners at high altitude in different climatic temperatures , 2010, International journal of biometeorology.
[7] A. von Deimling,et al. Ets‐1 is up‐regulated together with its target gene products matrix metalloproteinase‐2 and matrix metalloproteinase‐9 in atypical and anaplastic meningiomas , 2006, Histopathology.
[8] Hirotaka Yamamoto,et al. Role of the transcription factor Ets-1 in cisplatin resistance. , 2004, Molecular cancer therapeutics.
[9] S. Passi,et al. Imbalance in the antioxidant pool in melanoma cells and normal melanocytes from patients with melanoma. , 1996, The Journal of investigative dermatology.
[10] S. Kiriakidis,et al. The transcription factor ETS-1: its role in tumour development and strategies for its inhibition. , 2008, Mini reviews in medicinal chemistry.
[11] T. Tamaya,et al. Clinical implications of expression of ETS-1 related to angiogenesis in uterine cervical cancers. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[12] N. Holbrook,et al. Cellular response to oxidative stress: Signaling for suicide and survival * , 2002, Journal of cellular physiology.
[13] M. Abe,et al. ETS‐1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin β3 , 1999, Journal of cellular physiology.
[14] Robert Nadon,et al. A correction for estimating error when using the Local Pooled Error Statistical Test , 2008, Bioinform..
[15] Kai Chen,et al. Activation of p53 by Oxidative Stress Involves Platelet-derived Growth Factor-β Receptor-mediated Ataxia Telangiectasia Mutated (ATM) Kinase Activation* , 2003, Journal of Biological Chemistry.
[16] S. Weinhouse,et al. Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro. , 1953, Cancer research.
[17] R. Scarpulla,et al. Nuclear activators and coactivators in mammalian mitochondrial biogenesis. , 2002, Biochimica et biophysica acta.
[18] J. Nesland,et al. Ets-1 mRNA Expression in Effusions of Serous Ovarian Carcinoma Patients Is a Marker of Poor Outcome , 2001, The American journal of surgical pathology.
[19] Ann M. Hess,et al. which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Filtering for increased power for microarray data analysis , 2008 .
[20] O. Warburg. [Origin of cancer cells]. , 1956, Oncologia.
[21] M Schwaiger,et al. Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] C. Sweep,et al. Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer , 2002, Oncogene.
[23] H. Pelicano,et al. Mitochondrial dysfunction and reactive oxygen species imbalance promote breast cancer cell motility through a CXCL14-mediated mechanism. , 2009, Cancer research.
[24] Gurmit Singh,et al. ets‐1 is transcriptionally up‐regulated by H2O2 via an antioxidant response element , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[25] L. Oberley,et al. Antioxidant enzyme levels in cancer. , 1997, Histology and histopathology.
[26] M. Kaminski,et al. The potential of 2-deoxy-2[18F]fluoro-D-glucose (FDG) for the detection of tumor involvement in lymph nodes. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[27] John A. Hall,et al. mtDNA mutations increase tumorigenicity in prostate cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[28] J. Fagin,et al. Expression of the Ets-1 proto-oncogene in human gastric carcinoma: correlation with tumor invasion. , 1996, The American journal of pathology.
[29] N. Takai,et al. c-Ets1 is a promising marker in epithelial ovarian cancer. , 2002, International journal of molecular medicine.
[30] M. Trojanowska. Ets factors and regulation of the extracellular matrix , 2000, Oncogene.
[31] G. Semenza. Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.
[32] G. Schatz. Mitochondria: beyond oxidative phosphorylation. , 1995, Biochimica et biophysica acta.
[33] S. Dima,et al. Transcriptional silencing of ETS-1 efficiently suppresses angiogenesis of pancreatic cancer , 2009, Cancer Gene Therapy.
[34] S. Weinhouse,et al. Metabolism of neoplastic tissue. III. Diphosphopyridine nucleotide requirements for oxidations by mitochondria of neoplastic and non-neoplastic tissues. , 1953, Cancer research.
[35] P. Jansen-Dürr,et al. High-resolution respirometry–a modern tool in aging research , 2006, Experimental Gerontology.
[36] Peng Huang,et al. Mitochondrial defects in cancer , 2002, Molecular Cancer.
[37] K. Hallikeri,et al. Oxidant-antioxidant status in blood and tumor tissue of oral squamous cell carcinoma patients. , 2010, Oral diseases.
[38] C. Nathan,et al. Production of large amounts of hydrogen peroxide by human tumor cells. , 1991, Cancer research.
[39] J. Nesland,et al. Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[40] J. Klaunig,et al. The role of oxidative stress in carcinogenesis. , 2004, Annual review of pharmacology and toxicology.
[41] J. Ahn,et al. Ets-1 upregulates HER2-induced MMP-1 expression in breast cancer cells. , 2008, Biochemical and biophysical research communications.
[42] Jürgen Dittmer,et al. The Biology of the Ets1 Proto-Oncogene , 2003, Molecular Cancer.
[43] S. Erzurum,et al. Differential expression of manganese superoxide dismutase and catalase in lung cancer. , 2001, Cancer research.
[44] A. Bosserhoff,et al. The Ets-1 transcription factor is involved in the development and invasion of malignant melanoma , 2003, Cellular and Molecular Life Sciences CMLS.
[45] Benjamin M. Bolstad,et al. affy - analysis of Affymetrix GeneChip data at the probe level , 2004, Bioinform..
[46] G. Khomutov,et al. Superoxide generation by the respiratory chain of tumor mitochondria. , 1987, Biochimica et biophysica acta.
[47] N. Matevska,et al. Increased oxidative/nitrosative stress and decreased antioxidant enzyme activities in prostate cancer. , 2009, Clinical biochemistry.
[48] B. Manning,et al. Chewing the Fat on Tumor Cell Metabolism , 2010, Cell.
[49] Yau-Huei Wei,et al. Mitochondrial DNA Instability and Metabolic Shift in Human Cancers , 2009, International journal of molecular sciences.
[50] Oberley Td,et al. Antioxidant enzyme levels in cancer. , 1997 .